NCT04686916View on ClinicalTrials.gov

Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

July 30, 2023

Study Completion Date

August 30, 2023

Conditions
Erectile Dysfunction
Interventions
DRUG

IP2018

Test drug

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

RECRUITING

MAC, Manchester

Sponsors

Lead Sponsor

Initiator Pharma
All Listed Sponsors
lead

Initiator Pharma

INDUSTRY